120 related articles for article (PubMed ID: 2244404)
1. Correlation of free phenytoin to serum albumin in cancer patients.
Umstead GS; Neumann KH
DICP; 1990 Oct; 24(10):923-6. PubMed ID: 2244404
[TBL] [Abstract][Full Text] [Related]
2. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction.
Montgomery MC; Chou JW; McPharlin TO; Baird GS; Anderson GD
Pharmacotherapy; 2019 Jul; 39(7):756-766. PubMed ID: 31067355
[TBL] [Abstract][Full Text] [Related]
3. Prediction of free phenytoin levels based on [total phenytoin]/[albumin] ratios. Potential errors with hypoalbuminemia.
Dasgupta A; Dennen DA; Dean R; McLawhon RW
Am J Clin Pathol; 1991 Feb; 95(2):253-6. PubMed ID: 1992618
[TBL] [Abstract][Full Text] [Related]
4. Alteration of phenytoin binding by glycosylation of albumin in IDDM.
Kemp SF; Kearns GL; Turley CP
Diabetes; 1987 Apr; 36(4):505-9. PubMed ID: 3817304
[TBL] [Abstract][Full Text] [Related]
5. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
[TBL] [Abstract][Full Text] [Related]
6. Interpatient and intrapatient variability in phenytoin protein binding.
Banh HL; Burton ME; Sperling MR
Ther Drug Monit; 2002 Jun; 24(3):379-85. PubMed ID: 12021629
[TBL] [Abstract][Full Text] [Related]
7. Effect of glycated albumin on phenytoin binding in elderly patients with type II diabetes mellitus.
Kostic BA; Olsen KM; Kearns GL; Kemp SF
Pharmacotherapy; 1990; 10(5):362-5. PubMed ID: 2235672
[TBL] [Abstract][Full Text] [Related]
8. Estimating phenytoin concentrations by the Sheiner-Tozer method in adults with pronounced hypoalbuminemia.
Dager WE; Inciardi JF; Howe TL
Ann Pharmacother; 1995; 29(7-8):667-70. PubMed ID: 8520077
[TBL] [Abstract][Full Text] [Related]
9. A graphical nomogram method for predicting toxic concentrations of unbound phenytoin.
Pospisil J; Pelclová D
Int J Clin Pharmacol Ther; 1994 Mar; 32(3):122-5. PubMed ID: 8205372
[TBL] [Abstract][Full Text] [Related]
10. Plasma total phenytoin: a possibly misleading test in developing countries.
Fedler C; Stewart MJ
Ther Drug Monit; 1999 Apr; 21(2):155-60. PubMed ID: 10217333
[TBL] [Abstract][Full Text] [Related]
11. Temperature dependence of phenytoin-protein binding in serum: effects of uremia and hypoalbuminemia.
Allison TB; Comstock TJ
Ther Drug Monit; 1988; 10(4):376-81. PubMed ID: 3201522
[TBL] [Abstract][Full Text] [Related]
12. Free phenytoin assessment in patients: measured versus calculated blood serum levels.
Tobler A; Hösli R; Mühlebach S; Huber A
Int J Clin Pharm; 2016 Apr; 38(2):303-9. PubMed ID: 26746902
[TBL] [Abstract][Full Text] [Related]
13. Differences between the measured and calculated free serum phenytoin concentrations in epileptic patients.
Hong JM; Choi YC; Kim WJ
Yonsei Med J; 2009 Aug; 50(4):517-20. PubMed ID: 19718399
[TBL] [Abstract][Full Text] [Related]
14. Identifying patients who might benefit from free phenytoin monitoring.
Baird-Lambert J; Manglick MP; Wall M; Buchanan N
Ther Drug Monit; 1987 Jun; 9(2):134-8. PubMed ID: 3303467
[TBL] [Abstract][Full Text] [Related]
15. Phenytoin-oxacillin interactions in normal and uremic sera.
Dasgupta A; Sperelakis A; Mason A; Dean R
Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332
[TBL] [Abstract][Full Text] [Related]
16. Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.
Tiula E; Tallgren LG; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):545-52. PubMed ID: 3429058
[TBL] [Abstract][Full Text] [Related]
17. Effect of valproate on free plasma phenytoin concentrations.
Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
[TBL] [Abstract][Full Text] [Related]
18. Phenytoin loading in chronic alcoholic patients.
Welch RD; Smith DB; Danosi SF; Zwanger ML; Bock BF
Am J Emerg Med; 1988 Mar; 6(2):89-92. PubMed ID: 3355633
[TBL] [Abstract][Full Text] [Related]
19. Renal function and therapeutic concentrations of phenytoin.
Liponi DF; Winter ME; Tozer TN
Neurology; 1984 Mar; 34(3):395-7. PubMed ID: 6538287
[TBL] [Abstract][Full Text] [Related]
20. Correlation and prediction of phenytoin protein binding using standard laboratory parameters in patients after renal transplantation.
Monaghan MS; Marx MA; Olsen KM; Turner PD; Bergman KL
Ther Drug Monit; 2001 Jun; 23(3):263-7. PubMed ID: 11360036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
